CB
BBIO icon

Commerce Bank’s BridgeBio Pharma BBIO Stock Holding History

Commerce Bank’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$899K Buy
12,076
+160
+1% +$11.2K ﹤0.01% 774
2026
Q1 		$885K Buy
11,916
+175
+1% +$12.7K ﹤0.01% 754
2025
Q4 		$898K Sell
11,741
-50
-0.4% -$3.28K 0.01% 704
2025
Q3 		$612K Buy
11,791
+5,748
+95% +$280K ﹤0.01% 797
2025
Q2 		$261K Hold
6,043
– – ﹤0.01% 1084
2025
Q1 		$209K Buy
+6,043
New +$204K ﹤0.01% 1131
2024
Q1 		– Sell
-6,043
Closed -$244K – 1201
2023
Q4 		$244K Buy
+6,043
New +$181K ﹤0.01% 1076

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Commerce Bank's BBIO Position: Q2 2026 in Review

Commerce Bank increased its BridgeBio Pharma (BBIO) stake by 1.3% in Q2 2026, buying an estimated $11.2K and bringing the position to 12,076 shares worth $899K. The position accounts for ﹤0.01% of the portfolio, ranked #774.

Commerce Bank first reported a position in BBIO in Q4 2023 and has held it in 7 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Commerce Bank held 12,076 shares of BridgeBio Pharma worth $899K as of Q2 2026.
  • Commerce Bank bought 160 BridgeBio Pharma shares in Q2 2026, an estimated $11.2K.
  • BridgeBio Pharma made up ﹤0.01% of Commerce Bank's portfolio in Q2 2026, its #774 holding.
  • Commerce Bank first reported a position in BridgeBio Pharma in Q4 2023 and has held it in 7 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.